Article info

Download PDFPDF

FRI0238 Effect of baseline anti-cyclic citrullinated peptide 3 antibody titre on long-term drug survival of subcutaneous abatacept in rheumatoid arthritis: a prospective cohort study
Free

Authors

Citation

Sarmiento-Monroy J, Molano-González N, Rodríguez-Jiménez M, et al
FRI0238 Effect of baseline anti-cyclic citrullinated peptide 3 antibody titre on long-term drug survival of subcutaneous abatacept in rheumatoid arthritis: a prospective cohort study

Publication history

  • First published June 15, 2017.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.